metamizole
metamizole is a pharmaceutical drug with 11 clinical trials. Currently 1 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.0%
8 of 10 finished
20.0%
2 ended early
1
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs
TAP vs QLB in Patients After Cesarean Delivery
Evaluation of the Added Value of Metamizole to Standard Postoperative Treatment After Ambulant Shoulder Surgery
Impact of Intra- and Postoperative Continuous Infusion of Lidocaine on Analgesia in Vascular Anaesthesia
Evaluation of the Added Value of Metamizole to Standard Post-operative Treatment After Ambulant Surgery
Clinical Trials (11)
Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs
TAP vs QLB in Patients After Cesarean Delivery
Evaluation of the Added Value of Metamizole to Standard Postoperative Treatment After Ambulant Shoulder Surgery
Impact of Intra- and Postoperative Continuous Infusion of Lidocaine on Analgesia in Vascular Anaesthesia
Evaluation of the Added Value of Metamizole to Standard Post-operative Treatment After Ambulant Surgery
Postoperative Pain in Scheduled Craniotomy
Pharmacokinetic Interactions of Metamizole (Dipyrone) in Healthy Subjects
Pharmacokinetics of Intravenous Metamizole in Children Less Than 6 Years Old
Effect of Metamizole (Dipyrone) on Renal Function in Salt-depleted Healthy Subjects
Metamizol for the Treatment of Neoplastic Chronic Pain
Efficacy and Safety of Metamizole Versus Placebo as Antithermic Therapy in the Acute Phase of Ischemic Stroke
All 11 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 11